Safety Syringe Market Outlook 2024: Exclusive Report By The Business Research Company |Cardinal Health Inc., Retractable Technologies Inc., Thermo Fisher Scientific Inc., Medtronic plc, Novo Nordisk A/s, Becton, Dickinson and Company, Baxter International

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2192

The Business Research Company offers in-depth market insights through Safety Syringe Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The safety syringe market size has grown strongly in recent years. It will grow from $8.19 billion in 2023 to $8.95 billion in 2024 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to needlestick injury concerns, regulatory mandates, increased adoption of safety measures, increasing prevalence of blood-borne diseases, growing healthcare infrastructure.The safety syringe market size is expected to see strong growth in the next few years. It will grow to $12.6 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to vaccination initiatives, rising geriatric population, increased focus on preventive healthcare, expanding biopharmaceutical industry, advancements in material sciences. Major trends in the forecast period include rapid technological innovations, emphasis on sustainable solutions, telehealth integration, customized solutions for specialized therapeutics, enhanced emergency response and preparedness.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=13924&type=smp

Market Segmentation:
The safety syringe market covered in this report is segmented -

1) By Product: Retractable Safety Syringes, Non Retractable Safety Syringes
2) By Therapy: Insulin, Glucagon-like peptide-I (CLP-I), Tuberculosis, Growth Hormones
3) By Application: Subcutaneous, Intramuscular
4) By End-user: Hospitals, Ambulatory Surgical Centers, Long-term Care Facilities, Specialty Clinics, Other End Users

Major Driver - Surge in Blood-Borne Diseases Accelerates Demand for Safety Syringes in Healthcare
The rising number of blood-borne diseases is expected to propel the growth of the safety syringe market going forward. A blood-borne disease is an infectious disease caused by microorganisms, such as bacteria, viruses, or parasites, that are transmitted through the blood. The use of safety syringes is a proactive measure to protect healthcare workers and patients from the risks associated with blood-borne diseases by reducing the likelihood of accidental exposures and promoting best practices in medical procedures. For instance, in September 2023, according to Contagion Live, a US-based news source, the blood-borne infection rates increased by 14% in 2020-2021, and there were 5023 confirmed cases of hepatitis C virus (HCV), with an estimated 69,800 infections. Further, around 43 states in the US also reported 107,540 newly diagnosed cases of HCV. Therefore, the rising number of blood-borne diseases is driving the growth of the safety syringe market.

Competitive Landscape:
Major companies operating in the safety syringe market report are Cardinal Health Inc., Retractable Technologies Inc., Thermo Fisher Scientific Inc., Medtronic plc, Novo Nordisk A/s, Becton, Dickinson and Company, Baxter International Inc., Boston Scientific Corporation, Medline Industries LP, Terumo Corporation, B. Braun Melsungen AG, West Pharmaceutical Services Inc., Fresenius Kabi AG, Nemera, Smiths Medical International Ltd., Nipro Medical Corporation, Henke-Sass Wolf GmbH, Revolutions Medical iNC., Sol-Millennium Inc., UltiMed Inc., Unilife Corporation, AdvaCare Pharma, Axol Bio Corporation, Vita Needle Company, Numedico Technologies Pty Ltd., Duopross Meditech Corporation, DMC Medical Ltd., Guangdong Haiou Medical Apparatus Co. Ltd., Kendall Healthcare Group Ltd.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/safety-syringe-global-market-report

Top Trend - Product Innovations Transforming The Safety Syringe Market
Major companies operating in the safety syringe market are developing new products, such as passive needle guards, to gain a competitive edge in the market. A passive needle guard is a safety feature integrated into a medical device, such as a syringe, to enhance safety during and after use. For instance, in November 2021, Becton, Dickinson, and Company, a US-based medical device company, launched the BD UltraSafe Plus 2.25 mL Passive Needle Guard, an innovative addition to its drug delivery systems. This new solution extends the capabilities of the BD UltraSafe Plus needle guard platform, allowing the subcutaneous delivery of biologic solutions with volumes up to 2 mL and viscosities up to 30 cP. The design aims to address challenges related to the increasing viscosity and injection volume of biologics, providing a patient-controlled injection option for complex, high-viscosity drugs. The BD UltraSafe Plus 2.25 mL is designed to enhance the self-injection experience for patients, caregivers, and healthcare providers. The system aligns with the BD Neopak 2.25 mL Glass Prefillable Syringe, providing support for bio-pharmaceutical drug launches with convenience and ease of use.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Safety Syringe Market Characteristics
3. Safety Syringe Market Trends And Strategies
4. Safety Syringe Market - Macro Economic Scenario
5. Safety Syringe Market Size And Growth
…..
27. Safety Syringe Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.